Pages that link to "Q34545864"
Jump to navigation
Jump to search
The following pages link to Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231. (Q34545864):
Displaying 22 items.
- Assessment of in vivo and in vitro genotoxicity of glibenclamide in eukaryotic cells (Q28544944) (← links)
- Undariopsis peterseniana Promotes Hair Growth by the Activation of Wnt/β-Catenin and ERK Pathways (Q33744118) (← links)
- Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy (Q33756414) (← links)
- Altered expression of two-pore domain potassium (K2P) channels in cancer (Q35014316) (← links)
- Silencing of voltage-gated potassium channel KV9.3 inhibits proliferation in human colon and lung carcinoma cells (Q35781525) (← links)
- Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer (Q36922957) (← links)
- The promoting effect of Ishige sinicola on hair growth (Q37040024) (← links)
- Effects of sulfonylureas on tumor growth: a review of the literature (Q37247194) (← links)
- Cell proliferation, potassium channels, polyamines and their interactions: a mini review (Q38118863) (← links)
- Diabetes drugs and the incidence of solid cancers: a survey of the current evidence. (Q38651175) (← links)
- Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells (Q38871772) (← links)
- New insights into antidiabetic drugs: Possible applications in cancer treatment. (Q39272833) (← links)
- Glibenclamide, a diabetic drug, prevents acute radiation induced liver injury of mice via up-regulating intracellular ROS and subsequently activating Akt-NF-κB pathway (Q41092503) (← links)
- Statin and Bisphosphonate Induce Starvation in Fast-Growing Cancer Cell Lines. (Q41660477) (← links)
- Glibenclamide induces apoptosis by activating reactive oxygen species dependent JNK pathway in hepatocellular carcinoma cells (Q41926385) (← links)
- Metformin use and its effect on gastric cancer in patients with type 2 diabetes: A systematic review of observational studies (Q49183232) (← links)
- Gliclazide, a KATP channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ-AMPK pathway (Q50033960) (← links)
- Glipizide suppresses embryonic vasculogenesis and angiogenesis through targeting natriuretic peptide receptor A. (Q50594098) (← links)
- A novel computational approach for drug repurposing using systems biology. (Q52657953) (← links)
- Expression of KATP channels in human cervical cancer: Potential tools for diagnosis and therapy. (Q55231478) (← links)
- Emerging roles for multifunctional ion channel auxiliary subunits in cancer. (Q64901250) (← links)
- Evaluation of selected commercial pharmacotherapeutic drugs as potential pancreatic lipase inhibitors and antiproliferative compounds (Q90237753) (← links)